Blast crisis in a murine model of chronic myelogenous leukemia.
about
Zebrafish as a model for cancer self-renewalTowards a molecular understanding of polycythemia rubra vera.Dissecting the molecular mechanism of chronic myelogenous leukemia using murine models.The biology of chronic myelogenous leukemia:mouse models and cell adhesion.The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model.Studying the pathogenesis of BCR-ABL+ leukemia in mice.The PPARα agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism.Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies.Autografting for chronic myeloid leukaemia--palliation, cure or nothing?A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemiaEfficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice.The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disordersAnticipating clinical resistance to target-directed agents : the BCR-ABL paradigm.Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1.Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cellsHematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions.Insights into the stem cells of chronic myeloid leukemia.RNA binding protein MSI2 positively regulates FLT3 expression in myeloid leukemia.Illegitimate RAG-mediated recombination events are involved in IKZF1 Δ3-6 deletion in BCR-ABL1 lymphoblastic leukaemia.Disease progression in a murine model of bcr/abl leukemogenesis.Animal models of BCR/ABL-induced leukemias.BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression.Insights into the pathophysiology and therapy of myeloproliferative neoplasms from mouse modelsv-Abl-mediated apoptotic suppression is associated with SHC phosphorylation without concomitant mitogen-activated protein kinase activation.Rationalizing autotransplant strategies for chronic myeloid leukemia.The CML stem cell: evolution of the progenitor.Direct transplantation of chronic myelogenous leukemia cells into nude mice and establishment of a leukemic stem cell (Ph1+, CD34+) line dependent on mouse bone marrow stromal cells in vitro.Cancer: Bad blood promotes tumour progression.SHP2 is required for BCR-ABL1-induced hematologic neoplasia.Induction of Chronic Myeloid Leukemia in Mice.Cell biology of CML--a model linking the chronic and terminal phases.Structural organization of BCR-ABL gene in chronic phase and blast transformation in chronic myeloid leukemia patients.Reversibility of acute B-cell leukaemia induced by BCR-ABL1.
P2860
Q33584755-C9ED4F5E-D6F5-4459-9D3B-A8F78E976626Q33940318-261CEAD8-FFBC-4D41-A62F-A37DDA847B45Q34980358-ECD43368-66D0-43C2-88D8-5C994C90B2B5Q35022536-1279691B-C208-4E2D-9CFD-E14AB184467EQ35022540-1829CA3C-ABA6-4E36-B0CC-C0161BA6C563Q35022543-37214306-A807-4F70-833F-783A1922906DQ35092818-54203F62-44D5-490C-9D7D-83EDF587EFE6Q35166848-5AA16398-8A05-4E5F-8F09-6778C6D6F2DEQ35664722-A4C7DDC7-C842-4BBC-A018-63623E0FC79BQ36210636-BBD71BBC-F3DF-43B8-A446-ED1532112A55Q36262876-AE2FF4B2-52E9-4BE5-A248-E2E9164CE393Q36368162-D271E763-D536-4077-9EBD-B2A3D66BC9DFQ36374813-70C156A2-DA54-432E-80DD-2332B1B4E7DDQ36466443-4A03094B-93DF-4B95-9395-E1783704FA4DQ36780139-FE40C363-A2EB-4A68-A2D1-072B2466A4BDQ36843769-8A7F787E-AD8B-432D-8AA7-23FC19781A14Q36965464-6B3B4D1A-A90A-43C5-B75F-62E8A0B73FC0Q37791423-11617382-824F-4BA2-863F-C49E89D5219CQ38720331-BEF1B82E-DB42-42AC-9ED4-A349C7439264Q39751939-30F68A12-B896-4FD1-921C-DA4570C759AFQ40785957-2309C099-9AEF-4E96-B2BA-6353854F7697Q40785985-8D7122B3-C09B-4909-833E-9968247784F6Q40809849-D73F423A-2795-45BD-9961-42D68FD9D5A9Q40820007-FF53BAFA-B9C4-4136-AECE-9AE9E1929CB6Q41359429-37ABA587-611A-4F5B-B7F1-09F86A49AD69Q41489280-E5D1B7ED-EFD3-4ED5-9AFC-CBD500E2FDF2Q42135962-95CF9AB1-11FB-4A6F-8466-7857665E2614Q42803560-FE35AF52-C1B6-48EF-A3A2-F812C8C3AF2BQ44656536-C1E0E980-D0E6-4B37-A9F1-C70E7D69E71EQ46361900-46657012-22E5-4B29-A436-4FD02C98D4D0Q51540120-C9C01602-5148-4CB5-B3FC-559068A5FCFBQ53484472-D656E058-1523-4291-927B-BFAF4A488E9AQ53484480-28F9906C-292C-42ED-B6EA-D924E8CD6D6BQ55033528-D5071D2E-7C1A-4BE4-B5F0-CDE694D6856D
P2860
Blast crisis in a murine model of chronic myelogenous leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Blast crisis in a murine model of chronic myelogenous leukemia.
@en
Blast crisis in a murine model of chronic myelogenous leukemia.
@nl
type
label
Blast crisis in a murine model of chronic myelogenous leukemia.
@en
Blast crisis in a murine model of chronic myelogenous leukemia.
@nl
prefLabel
Blast crisis in a murine model of chronic myelogenous leukemia.
@en
Blast crisis in a murine model of chronic myelogenous leukemia.
@nl
P2093
P2860
P356
P1476
Blast crisis in a murine model of chronic myelogenous leukemia.
@en
P2093
D Baltimore
R A Van Etten
P2860
P304
11335-11338
P356
10.1073/PNAS.88.24.11335
P407
P577
1991-12-01T00:00:00Z